Joshua Hare | Director Of Interdisciplinary Stem Cell Institute
University of Miami Miller School of Medicine

Joshua Hare, Director Of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Dr. Joshua Hare is Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine.  Dr. Hare is an expert in cardiovascular medicine and specializes in heart failure, myocardial infarction, inflammatory diseases of the heart, and heart transplantation.  He is an internationally acknowledged pioneer in the field of stem cell therapeutics for human heart disease, currently seeing and evaluating patients from all over the world for this new experimental therapy.  Dr. Hare has published multiple clinical trials testing the use of mesenchymal stem cells in patients with heart or age related disorders and is the Principal Investigator of two major NHLBI programs that advance cell based therapy.


Conference Day 1: Thursday 16th May 2019 @ 09:30

Intravenous infusion of umbilical cord tissue (UC) derived Mesenchymal Stem Cells (MSCs) versus bone marrow (BM) derived MSCs to evaluate cytokine suppression in Patients with chronic inflammation due

  • A Phase I/II, Randomized, Placebo-controlled Comparative Study to compare Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.